UCLA Health is set to begin a multi-site pilot study to explore whether a ketogenic diet, when combined with mood stabilizing medications, helps stabilize mood symptoms in teenagers and young adults who have bipolar disorder.
Read more here!


UCLA Health is set to begin a multi-site pilot study to explore whether a ketogenic diet, when combined with mood stabilizing medications, helps stabilize mood symptoms in teenagers and young adults who have bipolar disorder.
Read more here!
SAN MATEO, Calif.–(BUSINESS WIRE)–Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy...
Read more
SAN MATEO, Calif.–(BUSINESS WIRE)–Baszucki Group today announced an expanded commitment to the landmark Cleveland Clinic Brain Study. Launched in 2022, this ambitious longitudinal study plans to follow healthy individuals...
Read more
Baszucki Group today announced the launch of the Metabolic Mind Fresh Start Award to empower individuals who have fought hard to win back their mental health. The Award honors the courage, strength, and resilience of individuals who have implemented ketogenic therapy to treat a serious mental illness. Awardees will receive a one-time prize of $10,000 to help them reach their goals.
Read more